Abstract: Viruses depend on their hosts at every stage of their life cycles and must therefore communicate with them via Protein-Protein Interactions (PPIs). To investigate the mechanisms of communication by different viruses, we overlay reported pairwise human-virus PPIs on human signalling pathways. Of 671 pathways obtained from NCI and Reactome databases, 355 are potentially targeted by at least one virus. The majority of pathways are linked to more than one virus. We find evidence supporting the hypothesis that viruses often interact with different proteins depending on the targeted pathway. Pathway analysis indicates overrepresentation of some pathways targeted by viruses. The merged network of the most statistically significant pathways shows several centrally located proteins, which are also hub proteins. Generally, hub proteins are targeted more frequently by viruses. Numerous proteins in virus-targeted pathways are known drug targets, suggesting that these might be exploited as potential new approaches to treatments against multiple viruses.
Introduction
Infectious diseases cause millions of deaths every year. New infectious diseases appear regularly in diverse parts of the globe, even as we fail to eradicate established diseases such as Acquired Immune Deficiency Syndrome (AIDS), malaria and tuberculosis. Virulent strains of known pathogens increasingly appear, as in the recent swine flu outbreak. Current treatments and vaccinations are focused on the pathogen. However, pathogens are able to adapt and rapidly evolve mechanisms to evade anti-bacterial and anti-viral drugs and vaccines. Moreover, once the pathogen has evaded the immune system, the infection may become chronic. Recent efforts in vaccine development therefore include targeting the host by combining pathogen-derived antigens with adjuvants, for example to boost the host immune system (Lederman, 1995) . New avenues for drug discovery may arise from study of the interactions between the pathogens and their hosts. When a pathogen invades a cell, it depends on the host's resources at all stages of its life cycle. To subvert the host cellular machinery for its purposes, the pathogen must communicate with the host, via chains of interactions referred to as signal transduction pathways. These allow cells to respond to the environment, and pathogens to take over the host.
Recently, more than 2500 interactions involving ~1000 human and 17 Human Immunodeficiency Virus (HIV) proteins have been catalogued (Fu et al., 2009) . While not all of these interactions may be based on physical contacts, this large number provides a glimpse into the extent of the communication between HIV and its human host, which is particularly remarkable considering the small number of HIV proteins. Small genome size is general for other viral genomes also, which typically encode less than 20 proteins. Increasingly, the interactions involving viruses other than HIV are also being catalogued, e.g., by the Pathogen Interaction Gateway (PIG) (Driscoll et al., 2009) and VirusMINT (Chatr-Aryamontri et al., 2009) efforts. These databases store information on PPIs between multiple hosts and pathogens. The VirusMINT database (Chatr-Aryamontri et al., 2009) integrates interactions involving proteins from 149 virus strains and their human binding partners, obtained from sources such as MINT (Zanzoni et al., 2002) , IntAct (Kerrien et al., 2007) and the HIV-1, Human Protein Interaction Database (Fu et al., 2009) . PIG, in addition to interactions with viruses, also includes bacteria (Driscoll et al., 2009 ). These efforts now allow a global view of the PPI networks between pathogens and their hosts. Earlier analysis of proteins targeted by pathogens including bacteria has revealed some common features that appear to be shared amongst several host-pathogen systems (Dyer et al., 2008) . The topological properties of proteins in the human PPI network indicate that pathogens target hub proteins, i.e., proteins that have many interacting partners, or bottlenecks, i.e., proteins that have many 'shortest paths' going through them (Dyer et al., 2008) . A common set of host proteins was identified that are frequently targeted by multiple pathogens, suggesting that at least some of the proteins targeted in humans are conserved across pathogens.
In this study, we strive to understand the functional significance of the interactions between pathogens and their hosts in the context of signal transduction pathways that may be disrupted or altered by PPIs involving the pathogens. The focus here is on viruses. A comparison of the potential effects of various pathogenic viruses on different signal transduction pathways in the host cell will allow addressing questions such as which viruses target the same pathways, which viruses target pathways that are less or not at all targeted by other viruses and which proteins are common targets for many viruses given the current interaction data. Addressing the above-mentioned questions is expected to advance our fundamental understanding of virus-host communication mechanisms and may help antiviral drug discovery.
Materials and methods

Pathway data and path identification
Pathway data was collected from the NCI and Reactome protein pathway databases (Matthews et al., 2009; Schaefer et al., 2009) in November 2008 and processed as described previously ). Only pathways under "Biomolecular interactions and cellular processes assembled into authoritative human signalling pathways" were downloaded from the PID website, http://pid.nci.nih.gov/. Thus, 671 pathways were analysed, representing 102 and 569 pathways from the NCI and Reactome databases, respectively.
Interactions data
Information on the interactions involving multiple viruses with human proteins was obtained from the VirusMINT database, which includes manually curated data as well as interactions downloaded from other databases (Chatr-Aryamontri et al., 2009) Some of the viruses reported in the VirusMINT database were very close relatives. We, therefore, grouped strains of the same virus as one category for each virus. The membership of different strains in their respective group is listed in Table 2 , along with the number of interactions that has been reported in the VirusMINT database for each group.
For hub analysis, two databases were used. First, to analyse human, HIV interactions, we used the NIAID database (Fu et al., 2009 ) and defined a subset of those interactions relating to direct physical interactions as described . Human PPIs were retrieved from the HPRD (Keshava Prasad et al., 2009) . Second, to compare all viruses, human PPI data was obtained from the Protein Interaction Network Analysis (PINA) platform (4 March 2010 release) ).
Curve fitting
Protein-pathway size dependency curves were fit by Matlab Inc. software using various standard regression techniques, including polynomial, linear, exponential, Weibull, fractional and Gaussian. A comparison of the performance of the fit for different functions and degrees was carried out by plotting the residual error and mean squared error for each fit. The smoothest fit was obtained by a polynomial function of degree 5, which is shown in Figure 2 .
Drug target and protein data
For all virus-targeted human proteins, we checked if they are listed as drug targets in DrugBank (Wishart et al., 2008) . The list of drug targets was obtained from DrugBank version 2.5. Additional functional information about the targeted proteins was obtained from the Protein knowledgebase (UniProtKB) (Apweiler et al., 2004) .
Network analysis
We used the Network Modules function in the Ingenuity Pathway Analysis (IPA, Ingenuity® Systems, http://www.ingenuity.com) to identify the enriched networks for the proteins targeted by viruses. These proteins (genes) were clustered into several networks based on their PPI, regulation and other relationships. Enrichment of networks was tested by right-tailed Fisher's exact test based on the hypergeometric distribution, and its p value was transformed to score by -log 10 p (Jia et al., 2011; Sun et al., 2010) . We used the Merge Networks function in IPA to merge top networks to have a more systematic view into the PPI features for virus targeting. Specifically in this study, we merged the top two networks to gain more insights into the function of genes and their relationships.
Results and discussion
An overall summary of the numbers of proteins and pathways investigated in this study with respect to their targeting by viruses with reference to the number of drug targets in the respective groups is provided in Table 1 . 
Global virus-pathway interactions
To obtain a general view of how many pathways are potentially targeted by known virus, human interactions, we enumerated the numbers of virus-interacting human proteins present in each pathway. The result is displayed in Figure 1 . To investigate if pathway targeting is correlated with the size of the pathways, we grouped the pathways according to the number of proteins in the pathways in bins of size 3. Then, we calculated the average number of viruses targeting at least one protein in each pathway group. The results are shown in Figure 2 . The results indicate that -as expected -pathways containing more proteins are more likely to be targeted by viruses. This statement is substantiated by fitting of the curve. The best result was obtained with a polynomial fit of degree 5.
Figure 2
Distribution of the average number of viruses that target at least one protein in a pathway. Bin size was 3, until the number of proteins reached 123, which only includes 7 pathways. The minimum sum of residuals was found for polynomial fit at degree = 5, shown here
Pathway targeting by different viruses
The 31 virus groups reported to have interactions with human proteins according to VirusMINT are listed in Table 2 . For CRPV, HEV and SeV, there are only 5, 3 and 1 interactions reported. These viruses were, therefore, omitted in our analysis. The remaining 28 viruses cover a range of species: 16 have a double-stranded DNA genome, 2 have a single-stranded RNA negative strand genome, 3 have a single-stranded RNA positive strand genome, 6 are retro-transcribing virus and one is a deltavirus. Nine virus groups, HIV, Human papillomavirus (HPV), EBV, Human adenovirus (HadV), Human herpes virus (HHV), Simian virus (SV), Vaccinia virus (VACV), Bovine papillomavirus (BPV) and FLUAV, have the maximum number of known interactions with human proteins. They interact with proteins in 289, 153, 121, 106, 139, 121, 62, 68 and 57 pathways, respectively. In the following, we briefly discuss the PPI of these nine groups, with particular emphasis on the cell surface receptors used by these viruses and the pathways most frequently targeted.
Human immunodeficiency virus-1 (HIV), the causative agent of AIDS, encodes 15 proteins (Frankel and Young, 1998) . The maximum number of interactions with human proteins has been reported for this virus. These interactions potentially affect 289 human pathways ( Table 2 ). The largest number of interactions (48) is with the proteins in the canonical NF-κB pathway. HIV initiates infection via the CD4 receptor (Maddon et al., 1986) , which participates in several pathways, including the canonical NF-κB pathway, Vpu-mediated degradation of CD4, IL12 signalling mediated by STAT4, IL23-mediated signalling events, downstream TCR signalling, Nef-Mediated CD4 down-regulation, ADP-ribosylation factor 1 pathway, binding and entry of HIV virion, translocation of ZAP-70 to immunological synapse, phosphorylation of CD3 and TCR zeta chains and generation of second messenger molecules pathways. In all of these pathways, HIV targets additional proteins apart from CD4. Human papillomavirus (HPV) leads to cervical cancer (Schiffman and Castle, 2003) . We grouped 10 types of HPV together (Table 2) . HPV encodes for 8 or 9 proteins depending on HPV subtype. HPV proteins are reported to be involved in 243 PPIs that potentially perturb 153 signal transduction pathways. TGF-β receptor signalling is the most frequently targeted pathway by HPV. 17 proteins of this pathway have been reported to interact with HPV. Other receptors such as α 6 integrin and laminin 5 are also involved in HPV infection. α 6 integrin participates in a6b1 and a6b4 Integrin signalling and Integrin cell surface interactions pathways. Laminin 5 is involved in integrin cell surface interactions pathways.
Bovine papillomavirus (BPV) encodes 8 proteins that have been shown to undergo 29 interactions with human proteins. These are predicted to perturb 68 pathways. BPV has its maximum number of interactions with proteins from the Sumoylation by RanBP2 regulates transcriptional repression pathway. 5 proteins of this pathway are targeted by BPV. Simian virus (SV) encodes 6 proteins, which are known to interact with 47 human proteins across 121 pathways. SV40 is a tumour-causing virus. The TGF-β receptor signalling pathway is the most frequently SV-targeted pathway involving interactions with 7 proteins.
Epstein-Barr virus (EBV) belongs to the
Vaccinia virus (VACV) with 254 proteins participates in 62 interactions with host proteins affecting 70 of analysed pathways. Proteins of canonical NF-κB pathway have the maximum number of interactions (5) with VACV proteins.
Influenza A (FLUAV) causes flu. Its genome encodes 11 proteins that undergo 12 interactions with human proteins affecting 57 pathways. The maximum number of interactions (5) is with proteins of the activation of the pre-replicative complex pathway.
Comparison of pathways across viruses
The above-mentioned analysis indicates that despite the differences in cell surface receptors recognised and required for entry, the different viruses subsequently may target overlapping signal transduction pathways. This is also supported by the relatively similar distribution of the numbers of pathways potentially affected by different viruses, shown Figure 4 gives the distribution of the number of pathways and number of proteins targeted by more than one virus. One can see that the number of proteins targeted by different viruses is smaller when compared with the number of pathways. This finding suggests that different viruses target a number of the same pathways by binding to different proteins. This implies that interactions may be conserved at the pathway level, rather than the protein level. It may be more critical for a virus to disrupt a particular pathway by any PPI that may do so, rather than restricting itself to a specific PPI. Pathway disruption may be conserved irrespective of the molecular mechanism of disruption.
Analysis at the pathway and protein level
Figure 4 Number of viruses targeting proteins and pathways
The above-mentioned analysis indicates that some viral proteins interact more with several host proteins when compared with others. A prime example of this is the TGF-β receptor signalling pathway, which is targeted by the maximum number of viruses (18). One possible explanation is because with 212 proteins this pathway is large (see Figure 2 for the general trend). Even more proteins participate in the canonical NF-κB pathway (739), and this pathway is also frequently targeted (by 16 viruses). However, there are other large pathways that are not frequently targeted, for example the electron transport chain has 78 proteins, yet only one has been shown to interact with a viral protein. Thus, it is likely that the frequent targeting of some pathways is functionally significant. To further investigate this observation, we screened the proteins targeted by viruses (among the 413 proteins with Uniprot ID, 411 could be mapped to gene symbols) using the IPA system (see Section 2). The network analysis resulted in 25 enriched networks whose statistical tests were significant (p < 10 -5 , score > 5). Table 4 lists 12 most significant networks whose scores were at least 20. We merged networks 1 and 2, both of which had functions related to infectious disease. Figure 5 shows the combined molecular network. As can be seen in the figure, NFKBIA, NFKB1 and NFKB2 are centrally located in the network, providing quantitative support for the finding described earlier, that viruses often target the NF-κB pathway. For many viruses, the largest number of interactions is with the proteins in the canonical NF-κB pathway (see earlier). 
Targeting of human hub proteins by viruses
NFKBIA, NFKB1 and NFKB2 are proteins that are generally referred to as hub proteins. Hub proteins are proteins that interact with many other proteins. According to the PINA database , these three proteins interact with 119, 192 and 195 other human proteins, respectively. To investigate if viruses generally target hub proteins, we first investigated HIV. A comparison between the degree of proteins randomly sampled when compared with those of the proteins interacting with HIV is shown in Figure 6 . This comparison shows that especially for proteins with degree above 10 the difference becomes very large. Since there is no standard definition of hub in a network, we defined three groups: hubs, intermediate hubs and non-hubs by degree >20, 10 ≤ degree < 20 and degree < 10, respectively. We then investigated these groups with respect to all virus groups. The results are shown in Table 5 . We found a clear inverse relationship between the percentage of proteins (hubs vs. non-hubs) in the pathways targeted by virus or not. This finding confirms that hub proteins are more likely targeted by viruses. 
Drug targets in virus-targeted pathways
The 671 signal transduction pathways are composed of 3039 unique proteins including 710 drug targets (Table 1 ). Figure 7 gives a distribution of the known drug targets in the pathways along with the drug targets that have a viral interacting partner. HIV has the maximum interactions with 219 human proteins, followed by HPV. Of the 671 signal transduction pathways investigated, 355 may be targeted by at least one virus. These 355 pathways have 413 proteins that interact with 28 different viruses. Amongst the 413 targeted proteins, 95 are known drug targets with 59 of those interacting with HIV viral proteins. Amongst the 355 targeted pathways, there are 268 that have at least one protein targeted by more than one virus. These 268 pathways have 93 unique proteins with which the various virus proteins interact. Thus, amongst all 671 pathways, there are 93 human proteins that interact with at least two pathogenic viruses. These 93 proteins are involved in a total of 774 interactions reported across the 268 pathways. We hypothesise that these 93 proteins may be potential drug targets for antiviral drugs against multiple viruses. According to the Drug Bank data, 23 proteins from these 93 proteins are known drug targets, i.e., there are ligands known to interact with these proteins. It would be interesting to test if these compounds have antiviral activity. MAV, HPV, HAdV, FLUAV, EBV, SV, VACV, ASV, RSV, FAdV, MPyV, HCV, HHV and HIV interact with the 23 drug targets from DrugBank. Approximately half of the drug targets in the pathways appear to be targeted by viruses. However, some pathways have significant higher number of drug targets compared with drug targets with reported virus interactions namely, Pathway 'A' Canonical NF-kappaB pathway, Pathway 'B' HIF-1-alpha transcription factor network, Pathway 'C' Vif-mediated degradation of APOBEC3G, Pathway 'D' Electron Transport Chain and Pathway 'E' Signalling mediated by p38-alpha and p38-beta
Conclusion
In this paper, we have explored human signal transduction pathways that are potentially targeted by virus-human PPI across different viruses. We find an increase in the number of pathways targeted with the size of the pathway targeted, but some pathways are over-represented in being a virus target. We find that viruses have the potential to target the same pathways, albeit not necessarily via the same PPIs, indicating commonalities in their hijack strategies. One such common strategy is to target hub proteins. It has previously been noted that the EBV targets high degree human proteins (Calderwood et al., 2007) and pathogens in general tend to interact with host proteins with high degrees and betweenness centrality (Dyer et al., 2008) . Finally, we need to note that the validity of any global analysis on the protein interaction data is dependent on the quality of the experimental data. The interaction data, in general, are derived through different experiments and experimental conditions and the resulting sets of protein interactions are more likely to include false positive and negative pairs as well as sample bias. Because of this lack of gold standard data sets, any conclusion that is based on protein interaction data sets should be taken with a grain of salt. However, this type of global views has still the potential to lead us to valuable findings regarding the general phenomena of how organisms work and communicate.
